Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6–infected infants with or without febrile seizures

Journal of Infection and Chemotherapy - Tập 20 - Trang 716-721 - 2014
Setsuaki Kittaka1, Shunji Hasegawa1, Yoshinori Ito2, Noriko Ohbuchi3, Eitaro Suzuki4, Shoji Kawano5, Yoshiharu Aoki6, Kenji Nakatsuka7, Keiko Kudo1, Hiroyuki Wakiguchi1, Madoka Kajimoto1, Takeshi Matsushige1, Takashi Ichiyama1
1Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan
2Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan
3Department of Pediatrics, Yamaguchi Red Cross Hospital, Japan
4Department of Pediatrics, Suzuki Pediatric Clinic, Japan
5Department of Pediatrics, Shimonoseki City Hospital, Japan
6Department of Pediatrics, Nagato General Hospital, Japan
7Department of Pediatrics, Toyoura Hospital, Japan

Tài liệu tham khảo

Asaoka, 2004, Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings, Intern Med, 43, 42, 10.2169/internalmedicine.43.42 Chakraborti, 2003, Regulation of matrix metalloproteinases: an overview, Mol Cell Biochem, 253, 269, 10.1023/A:1026028303196 Yoshikawa, 2000, Central nervous system complications in human herpesverus-6 infection, Brain Dev, 22, 307, 10.1016/S0387-7604(00)00113-3 Millichap, 2006, Role of viral infections in the etiology of febrile seizures, Pediatr Neurol, 35, 165, 10.1016/j.pediatrneurol.2006.06.004 Chandler, 1997, Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview, J Neuroimmunol, 72, 155, 10.1016/S0165-5728(96)00179-8 Lukes, 1999, Extracellular matrix degradation by metalloproteinases and central nervous system diseases, Mol Neurobiol, 19, 267, 10.1007/BF02821717 Murphy, 1997, Relating matrix metalloproteinase structure to function: why the “hemopexin” domain?, Matrix Biol, 15, 511, 10.1016/S0945-053X(97)90025-1 Krizanac-Bengez, 2006, Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood–brain barrier model: role of proinflammatory cytokines, Am J Physiol Cell Physiol, 291, 740, 10.1152/ajpcell.00516.2005 Sellner, 2006, In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation, Neurobiol Dis, 21, 647, 10.1016/j.nbd.2005.09.007 Forster, 2007, Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND, J Physiol, 580, 937, 10.1113/jphysiol.2007.129007 Kimura, 2005, Differences between T cell-type and natural killer cell-type chronic active Epstein–Barr virus infection, J Infect Dis, 191, 531, 10.1086/427239 Wada, 2007, Simultaneous quantification of Epstein–Barr virus, cytomegalovirus, and human herpes virus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay, J Clin Microbiol, 45, 1426, 10.1128/JCM.01515-06 Wada, 2009, Multiplex real-time PCR for the simultaneous detection of herpes simplex virus, human herpesvirus 6, and human herpesvirus 7, Microbiol Immunol, 53, 22, 10.1111/j.1348-0421.2008.00090.x Yamamoto, 2006, TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure, J Surg Res, 134, 307, 10.1016/j.jss.2005.11.588 Ichiyama, 2006, Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis, J Neuroimmunol, 172, 182, 10.1016/j.jneuroim.2005.10.010 Ichiyama, 2007, Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis, J Neurol Sci, 252, 45, 10.1016/j.jns.2006.10.005 Ichiyama, 2008, Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis, J Infect, 56, 376 Ichiyama, 2007, Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy, Pediatr Infect Dis J, 26, 542, 10.1097/INF.0b013e31803994a0 Suenaga, 2008, Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures, J Neurol Sci, 266, 126, 10.1016/j.jns.2007.09.011 Shiraishi, 2008, Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy, J Neuroimmunol, 196, 147, 10.1016/j.jneuroim.2008.02.012 Sunagawa, 2009, Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia, Brain Dev, 31, 588, 10.1016/j.braindev.2008.09.001 Ichiyama, 2009, Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis, J Neurol, 256, 1846 Chao, 2009, Production and roles of glial tissue inhibitor of metalloproteinases-1 in human immunodeficiency virus-1-associated dementia neuroinflammation: a review, Am J Infect Dis, 5, 314 Coussens, 2000, MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, Cell, 103, 481, 10.1016/S0092-8674(00)00139-2 Kelly, 2000, Increased matrix metalloproteinase-9 in the airway after allergen challenge, Am J Respir Crit Care Med, 162, 1157, 10.1164/ajrccm.162.3.9908016 Johnatty, 1997, Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes, J Immunol, 158, 2327, 10.4049/jimmunol.158.5.2327 Brew, 2000, Tissue inhibitors of metalloproteinases: evolution, structure and function, Biochim Biophys Acta, 1477, 267, 10.1016/S0167-4838(99)00279-4 Shinji, 2010, Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy, J Med Virol, 82, 1410, 10.1002/jmv.21808